BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26192312)

  • 1. Perflutren-Induced Angioedema.
    Gupta A; Harris S; Naina H
    Echocardiography; 2015 Aug; 32(8):1329. PubMed ID: 26192312
    [No Abstract]   [Full Text] [Related]  

  • 2. Echocardiography: fatal reactions to contrast agents.
    Prescrire Int; 2008 Dec; 17(98):245. PubMed ID: 19425266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab?
    Kutlu A; Karabacak E; Aydin E; Ozturk S; Bozkurt B
    Hum Exp Toxicol; 2014 Aug; 33(8):882-5. PubMed ID: 24203455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic instability after receiving intravenous Perflutren for contrast echocardiography in an elderly female.
    Blokh I; Ganem A; Bonaros EP; Stephen BD; Steinberg B; Rosen SE
    Echocardiography; 2004 Oct; 21(7):613-5. PubMed ID: 15488089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk.
    Goldberg YH; Ginelli P; Siegel R; Ostfeld RJ; Schaefer M; Spevack DM
    Cardiology; 2012; 122(2):119-25. PubMed ID: 22813648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergy to barium sulfate suspension with angioedema of the stomach and small bowel.
    Shaffer HA; Eckard DA; de Lange EE; Ramakrishnan MR
    Gastrointest Radiol; 1988 Jul; 13(3):221-3. PubMed ID: 3384266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography.
    Herzog CA
    JAMA; 2008 May; 299(17):2023-5. PubMed ID: 18460662
    [No Abstract]   [Full Text] [Related]  

  • 8. Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts.
    Kalra A; Shroff GR; Erlien D; Gilbertson DT; Herzog CA
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):206-7. PubMed ID: 24524748
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe angioedema associated with olmesartan.
    Vasquez JL; Jaramillo JC; Fernandez C; Enriquez A; Mielgo R
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):285. PubMed ID: 21875552
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden death after intravenous administration of a perflutren contrast agent: a case of pseudocomplication?
    Mahjoub H; Roméo P; Leung TK; Burelle D; Cartier R; Basmadjian AJ
    J Am Soc Echocardiogr; 2009 Jun; 22(6):753.e5-8. PubMed ID: 19269782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).
    Main ML; Ryan AC; Davis TE; Albano MP; Kusnetzky LL; Hibberd M
    Am J Cardiol; 2008 Dec; 102(12):1742-6. PubMed ID: 19064035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitor induced angioedema of the head and neck.
    DiNardo LJ; Hendrix RA; Anderson G; DeDio RM
    Trans Pa Acad Ophthalmol Otolaryngol; 1990; 42():998-1001. PubMed ID: 2085001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioedema complicating lisinopril therapy.
    Nzerue MC
    Cent Afr J Med; 1992 Sep; 38(9):391-2. PubMed ID: 1338526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angioedema due to losartan].
    Orgaz-Molina J; Soriano-Hernández MI; Husein-Elahmed H; Arias-Santiago S
    Med Clin (Barc); 2011 Sep; 137(6):281-2. PubMed ID: 21295793
    [No Abstract]   [Full Text] [Related]  

  • 15. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
    Kowalski ML; Woessner K; Sanak M
    J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies.
    Kusnetzky LL; Khalid A; Khumri TM; Moe TG; Jones PG; Main ML
    J Am Coll Cardiol; 2008 Apr; 51(17):1704-6. PubMed ID: 18436124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2 cases of allergic reaction after sialography].
    Drízhal I; Hrdinová V; Nováková J
    Cesk Stomatol; 1971 May; 71(3):166-9. PubMed ID: 4327016
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pseudoallergic reactions].
    Strejcek J; Starsia A; Jíra M
    Bratisl Lek Listy; 1988 Aug; 89(8):606-10. PubMed ID: 3179768
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats.
    Miller DL; Li P; Dou C; Gordon D; Edwards CA; Armstrong WF
    Radiology; 2005 Oct; 237(1):137-43. PubMed ID: 16183929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock).
    Limsuwan T; Demoly P
    Med Clin North Am; 2010 Jul; 94(4):691-710, x. PubMed ID: 20609858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.